Skip to main content

Microbot Medical Inc.

MBOT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000883975

No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Microbot Medical Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of MBOT: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders2639+13
Shares1.04M1.10M+59.4K (+5.7%)
Value$933.4K$1.24M+$302.2K (+32.4%)

New holders (14)

Institutions that held Microbot Medical Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to MBOT in Q4 2024
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC105,658$118.3K0.00%
Susquehanna International Group, LLP29,728$33.3K0.00%
Scotia Capital Inc.13,275$14.9K0.00%
Truist Financial Corp10,000$11.3K0.00%
SBI Securities Co., Ltd.2,963$3.32K0.00%
Transce3nd, LLC330$3700.00%
Lee Danner & Bass Inc100$1120.00%
JPMorgan Chase & Co38$430.00%
MAI Capital Management1$20.00%
Atala Financial Inc2$20.00%
FMR LLC1$10.00%
Jones Financial Companies LLLP1$10.00%
Financially Speaking Inc1$10.00%
Evelyn Partners Investment Management Services Ltd1$10.00%

Sold out (1)

Institutions that held Microbot Medical Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of MBOT in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Indiana Trust & Investment Management CO900$805